Tin tức & Cập nhật
Xem bài viết Dược
Xem
Chỉ hiển thị Multimedia

Vibegron relieves OAB symptoms in men treated for BPH
27 Jul 2024
bởiStephen Padilla
Treatment with vibegron significantly improves overactive bladder (OAB) symptoms in men who are being treated for benign prostatic hyperplasia (BPH), including daily micturitions and urgency episodes, results from the phase III COURAGE trial have shown. It is well tolerated and has an acceptable safety profile, with adverse event (AE) rates similar to placebo.
27 Jul 2024

Real-world data favour tirzepatide over semaglutide for weight loss
25 Jul 2024
bởiJairia Dela Cruz
Tirzepatide appears to yield substantially greater reductions in weight than semaglutide in the real-world treatment of overweight or obesity in adults with or without diabetes, according to a study.
25 Jul 2024






